- Home
- CRBU vs PRPL Comparison
CRBU vs PRPL Comparison
Compare CRBU & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- PRPL
- Stock Information
- Founded
- CRBU 2011
- PRPL 2010
- Country
- CRBU United States
- PRPL United States
- Employees
- CRBU N/A
- PRPL N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- PRPL Home Furnishings
- Sector
- CRBU Health Care
- PRPL Consumer Discretionary
- Exchange
- CRBU Nasdaq
- PRPL Nasdaq
- Market Cap
- CRBU 93.0M
- PRPL 78.9M
- IPO Year
- CRBU 2021
- PRPL N/A
- Fundamental
- Price
- CRBU $1.63
- PRPL $0.73
- Analyst Decision
- CRBU Strong Buy
- PRPL Hold
- Analyst Count
- CRBU 4
- PRPL 2
- Target Price
- CRBU $8.50
- PRPL $1.25
- AVG Volume (30 Days)
- CRBU 1.9M
- PRPL 710.9K
- Earning Date
- CRBU 08-05-2025
- PRPL 08-04-2025
- Dividend Yield
- CRBU N/A
- PRPL N/A
- EPS Growth
- CRBU N/A
- PRPL N/A
- EPS
- CRBU N/A
- PRPL N/A
- Revenue
- CRBU $9,918,000.00
- PRPL $472,015,000.00
- Revenue This Year
- CRBU $9.52
- PRPL N/A
- Revenue Next Year
- CRBU N/A
- PRPL $10.65
- P/E Ratio
- CRBU N/A
- PRPL N/A
- Revenue Growth
- CRBU N/A
- PRPL N/A
- 52 Week Low
- CRBU $0.66
- PRPL $0.56
- 52 Week High
- CRBU $3.00
- PRPL $1.50
- Technical
- Relative Strength Index (RSI)
- CRBU 66.57
- PRPL 46.90
- Support Level
- CRBU $1.34
- PRPL $0.70
- Resistance Level
- CRBU $1.79
- PRPL $0.74
- Average True Range (ATR)
- CRBU 0.12
- PRPL 0.05
- MACD
- CRBU 0.03
- PRPL -0.00
- Stochastic Oscillator
- CRBU 72.84
- PRPL 25.46
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.